INTEGRA CLOSES ACQUISITION OF NEWDEAL

Integra LifeSciences, a maker of skin grafts and surgical instruments, has acquired the Newdeal Technologies group of companies for roughly $53 million in cash, subject to certain adjustments.

The company's acquisition of Newdeal, a maker of reconstructive surgery products, is a move to bolster its offerings for foot and ankle surgery.

Integra first announced the deal in November 2004, estimating a slightly lower price. Company officials said they expect Newdeal's products to complement its regenerative skin products used to treat wounds of the foot and ankle.